Gehe tops UniChem's agreed bid for Lloyds

MAGNUS GRIMOND

Lloyds Chemists, owner of Britain's second-biggest pharmacy chain, was yesterday at the centre of a bitter battle for control as the German group Gehe trumped UniChem's already agreed offer with a pounds 584m all-cash bid.

The market had been expecting Gehe to move after it was forced to admit that it was holding discussions with Lloyds last week, but the shares jumped 23p to 467p - 17p above the 450p Gehe offer - as the market anticipated a yet-higher offer from UniChem.

Lloyds switched from backing the UniChem offer and said last night it recommended shareholders to accept Gehe's new bid - in the absence of a higher offer.

UniChem said it was still considering its response. Its current cash- and-shares offer is worth 408p a share, after a 3p rise in the share price to 248p. Analysts calculate that UniChem could justify a bid as high as 500p without suffering earnings dilution. But with gearing already set to hit 140 per cent after the lower offer, observers believe that would push the company close to its self-imposed limit that interest should be covered at least five times by profits.

One analyst said: "The consensus around and about [the City] seems to be it could put another pounds 1 on its bid. But it is interesting they have gone away to think about it, given that they have known that a bid was coming for some time."

Whatever happens, Lloyds' chairman, Allen Lloyd, will come out ahead. His personal stake is valued at pounds 41m by the Gehe bid, pounds 3m more than under UniChem's.

Observers were surprised that Gehe had not come in with a knock-out blow at around 480p to 500p, leading to speculation that its bid may be a spoiler to push the price up for UniChem. Last year, the German group, already Europe's biggest drug wholesaling group, spent pounds 400m in a contested bid for AAH, which controls close to a third of the UK drug wholesale market excluding Boots, a similar market share figure to UniChem's. A combination with Lloyds would take its share to around 39 per cent and add 900 pharmacies to the 295 outlets owned by AAH, creating the second-biggest chain after Boots.

Ray Bowden at Robert Fleming said the dual interest in Lloyds "has all the ingredients of a scrap". Both bidders badly want to get their hands on Lloyds, and both will be disadvantaged if they do not. This is a unique opportunity, he said, "because both of the bidders are below critical scale, particularly because of the synergies to be gained from distribution and retail. So to the extent that one benefits, the other suffers".

Dieter Kammerer, Gehe's chairman, said he expected the cost savings from a merger to be similar to the pounds 15m-pounds 20m that UniChem has quoted. "This is definitely the potential, but the time-frame could be expected to be longer... than UniChem [thinks]."

Dr Kammerer estimated that the forecast savings would not be achieved for three to four years, although he refused to specify where they would come. He said all activities other than the chemists' shops and the wholesale side, would be placed under review. However, there were no plans to sell any assets as yet and businesses like the Holland & Barrett healthfood chain and the Farillon agency pharmaceutical distribution operation may be kept.

Dr Kammerer denied speculation that Gehe, which is in effect controlled by the Haniel family, would have difficulty financing a bid.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Software Development Manager

£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

Ashdown Group: Product Manager - (Product Marketing, Financial Services)

£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Day In a Page

Isis hostage crisis: The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power

Isis hostage crisis

The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power, says Robert Fisk
Missing salvage expert who found $50m of sunken treasure before disappearing, tracked down at last

The runaway buccaneers and the ship full of gold

Salvage expert Tommy Thompson found sunken treasure worth millions. Then he vanished... until now
Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Maverick artist Grayson Perry backs our campaign
Assisted Dying Bill: I want to be able to decide about my own death - I want to have control of my life

Assisted Dying Bill: 'I want control of my life'

This week the Assisted Dying Bill is debated in the Lords. Virginia Ironside, who has already made plans for her own self-deliverance, argues that it's time we allowed people a humane, compassionate death
Move over, kale - cabbage is the new rising star

Cabbage is king again

Sophie Morris banishes thoughts of soggy school dinners and turns over a new leaf
11 best winter skin treats

Give your moisturiser a helping hand: 11 best winter skin treats

Get an extra boost of nourishment from one of these hard-working products
Paul Scholes column: The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him

Paul Scholes column

The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
Frank Warren column: No cigar, but pots of money: here come the Cubans

Frank Warren's Ringside

No cigar, but pots of money: here come the Cubans
Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

Isis stands strong as its numerous enemies fail to find a common plan to defeat it

The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

Virtual reality: Seeing is believing

Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
Homeless Veterans appeal: MP says Coalition ‘not doing enough’

Homeless Veterans appeal

MP says Coalition ‘not doing enough’ to help
Larry David, Steve Coogan and other comedians share stories of depression in new documentary

Comedians share stories of depression

The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
Has The Archers lost the plot with it's spicy storylines?

Has The Archers lost the plot?

A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
English Heritage adds 14 post-war office buildings to its protected lists

14 office buildings added to protected lists

Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Scientists unearthed the cranial fragments from Manot Cave in West Galilee